|
SE8205892D0
(sv)
|
1982-10-18 |
1982-10-18 |
Bror Morein |
Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
|
|
IL73534A
(en)
|
1983-11-18 |
1990-12-23 |
Riker Laboratories Inc |
1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
|
|
US6090406A
(en)
|
1984-04-12 |
2000-07-18 |
The Liposome Company, Inc. |
Potentiation of immune responses with liposomal adjuvants
|
|
US5916588A
(en)
|
1984-04-12 |
1999-06-29 |
The Liposome Company, Inc. |
Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4777127A
(en)
|
1985-09-30 |
1988-10-11 |
Labsystems Oy |
Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus
|
|
US4680338A
(en)
|
1985-10-17 |
1987-07-14 |
Immunomedics, Inc. |
Bifunctional linker
|
|
US5011828A
(en)
|
1985-11-15 |
1991-04-30 |
Michael Goodman |
Immunostimulating guanine derivatives, compositions and methods
|
|
GB8702816D0
(en)
|
1987-02-07 |
1987-03-11 |
Al Sumidaie A M K |
Obtaining retrovirus-containing fraction
|
|
US5219740A
(en)
|
1987-02-13 |
1993-06-15 |
Fred Hutchinson Cancer Research Center |
Retroviral gene transfer into diploid fibroblasts for gene therapy
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
US5206152A
(en)
|
1988-04-08 |
1993-04-27 |
Arch Development Corporation |
Cloning and expression of early growth regulatory protein genes
|
|
US5422120A
(en)
|
1988-05-30 |
1995-06-06 |
Depotech Corporation |
Heterovesicular liposomes
|
|
AP129A
(en)
|
1988-06-03 |
1991-04-17 |
Smithkline Biologicals S A |
Expression of retrovirus gag protein eukaryotic cells
|
|
AU627226B2
(en)
|
1988-08-25 |
1992-08-20 |
Liposome Company, Inc., The |
Influenza vaccine and novel adjuvants
|
|
DE3841091A1
(de)
|
1988-12-07 |
1990-06-13 |
Behringwerke Ag |
Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung
|
|
US5238944A
(en)
|
1988-12-15 |
1993-08-24 |
Riker Laboratories, Inc. |
Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
|
|
ES2055785T3
(es)
|
1989-01-17 |
1994-09-01 |
Eniricerche Spa |
Peptidos sinteticos y su uso como vehiculos universales para la preparacion de conjugados inmunogenos aptos para el desarrollo de vacunas sinteticas.
|
|
EP0454781B1
(en)
|
1989-01-23 |
1998-12-16 |
Chiron Corporation |
Recombinant cells for therapies of infection and hyperproliferative disorders and preparation thereof
|
|
JP3250802B2
(ja)
|
1989-03-21 |
2002-01-28 |
バイカル・インコーポレイテッド |
脊椎動物における外因性ポリヌクレオチド配列の発現
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
US4929624A
(en)
|
1989-03-23 |
1990-05-29 |
Minnesota Mining And Manufacturing Company |
Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
|
|
HU212924B
(en)
|
1989-05-25 |
1996-12-30 |
Chiron Corp |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
|
US5334379A
(en)
|
1989-07-14 |
1994-08-02 |
American Cyanamid Company |
Cytokine and hormone carriers for conjugate vaccines
|
|
CA2066053C
(en)
|
1989-08-18 |
2001-12-11 |
Harry E. Gruber |
Recombinant retroviruses delivering vector constructs to target cells
|
|
US5585362A
(en)
|
1989-08-22 |
1996-12-17 |
The Regents Of The University Of Michigan |
Adenovirus vectors for gene therapy
|
|
US4988815A
(en)
|
1989-10-26 |
1991-01-29 |
Riker Laboratories, Inc. |
3-Amino or 3-nitro quinoline compounds which are intermediates in preparing 1H-imidazo[4,5-c]quinolines
|
|
IT1237764B
(it)
|
1989-11-10 |
1993-06-17 |
Eniricerche Spa |
Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
|
|
ZA911974B
(en)
|
1990-03-21 |
1994-08-22 |
Res Dev Foundation |
Heterovesicular liposomes
|
|
US5658731A
(en)
|
1990-04-09 |
1997-08-19 |
Europaisches Laboratorium Fur Molekularbiologie |
2'-O-alkylnucleotides as well as polymers which contain such nucleotides
|
|
SE466259B
(sv)
|
1990-05-31 |
1992-01-20 |
Arne Forsgren |
Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
|
|
US5149655A
(en)
|
1990-06-21 |
1992-09-22 |
Agracetus, Inc. |
Apparatus for genetic transformation
|
|
IL98715A0
(en)
|
1990-08-13 |
1992-07-15 |
American Cyanamid Co |
Filamentous hemaglutinin of bodetella pertussis as a carrier molecule for conjugate vaccines
|
|
DK0563278T3
(da)
|
1990-12-20 |
2000-08-21 |
Dana Farber Cancer Inst Inc |
Regulering af geneekspression med ioniserende stråling
|
|
US5389640A
(en)
|
1991-03-01 |
1995-02-14 |
Minnesota Mining And Manufacturing Company |
1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
|
WO1992015582A1
(en)
|
1991-03-01 |
1992-09-17 |
Minnesota Mining And Manufacturing Company |
1-SUBSTITUTED, 2-SUBSTITUTED 1H-IMIDAZO[4,5-c]QUINOLIN-4-AMINES
|
|
DK0648271T3
(da)
|
1991-08-20 |
2003-07-21 |
Us Gov Health & Human Serv |
Adenovirusmedieret overførsel af gener til mave-/tarmkanal
|
|
US5268376A
(en)
|
1991-09-04 |
1993-12-07 |
Minnesota Mining And Manufacturing Company |
1-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
|
US5266575A
(en)
|
1991-11-06 |
1993-11-30 |
Minnesota Mining And Manufacturing Company |
2-ethyl 1H-imidazo[4,5-ciquinolin-4-amines
|
|
WO1993010218A1
(en)
|
1991-11-14 |
1993-05-27 |
The United States Government As Represented By The Secretary Of The Department Of Health And Human Services |
Vectors including foreign genes and negative selective markers
|
|
GB9125623D0
(en)
|
1991-12-02 |
1992-01-29 |
Dynal As |
Cell modification
|
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
|
FR2688514A1
(fr)
|
1992-03-16 |
1993-09-17 |
Centre Nat Rech Scient |
Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
|
|
IL105325A
(en)
|
1992-04-16 |
1996-11-14 |
Minnesota Mining & Mfg |
Immunogen/vaccine adjuvant composition
|
|
EP0650370A4
(en)
|
1992-06-08 |
1995-11-22 |
Univ California |
METHODS AND COMPOSITIONS TARGETED ON SPECIFIC TISSUES.
|
|
JPH09507741A
(ja)
|
1992-06-10 |
1997-08-12 |
アメリカ合衆国 |
ヒト血清による不活性化に耐性のあるベクター粒子
|
|
UA40597C2
(uk)
|
1992-06-25 |
2001-08-15 |
Смітклайн Бічем Байолоджікалс С.А. |
Вакцинна композиція,спосіб лікування ссавців, що страждають або сприйнятливі до інфекції, спосіб лікування ссавців, що страждають на рак, спосіб одержання вакцинної композиції, композиція ад'ювантів
|
|
IL102687A
(en)
|
1992-07-30 |
1997-06-10 |
Yeda Res & Dev |
Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
|
|
GB2269175A
(en)
|
1992-07-31 |
1994-02-02 |
Imperial College |
Retroviral vectors
|
|
EP1024198A3
(en)
|
1992-12-03 |
2002-05-29 |
Genzyme Corporation |
Pseudo-adenoviral vectors for the gene therapy of haemophiliae
|
|
US5395937A
(en)
|
1993-01-29 |
1995-03-07 |
Minnesota Mining And Manufacturing Company |
Process for preparing quinoline amines
|
|
EP1175912A1
(en)
|
1993-03-23 |
2002-01-30 |
SmithKline Beecham Biologics SA |
Vaccine compositions containing 3-O deacylated monophosphoryl lipid A
|
|
WO1994023697A1
(en)
|
1993-04-22 |
1994-10-27 |
Depotech Corporation |
Cyclodextrin liposomes encapsulating pharmacologic compounds and methods for their use
|
|
DE69423383T2
(de)
|
1993-05-13 |
2000-08-24 |
American Cyanamid Co., Wayne |
Herstellung und Verwendungen von LOS-verminderten Aussenmembran-Proteinen von Gram-negativen Kokken
|
|
DE69434486T2
(de)
|
1993-06-24 |
2006-07-06 |
Advec Inc. |
Adenovirus vektoren für gentherapie
|
|
US5352784A
(en)
|
1993-07-15 |
1994-10-04 |
Minnesota Mining And Manufacturing Company |
Fused cycloalkylimidazopyridines
|
|
ES2149276T3
(es)
|
1993-07-15 |
2000-11-01 |
Minnesota Mining & Mfg |
Imidazo(4,5-c)piridin-4-aminas.
|
|
US6015686A
(en)
|
1993-09-15 |
2000-01-18 |
Chiron Viagene, Inc. |
Eukaryotic layered vector initiation systems
|
|
EP0814154B1
(en)
|
1993-09-15 |
2009-07-29 |
Novartis Vaccines and Diagnostics, Inc. |
Recombinant alphavirus vectors
|
|
DE69434594T2
(de)
|
1993-10-25 |
2006-09-21 |
Canji, Inc., San Diego |
Rekombinante adenoviren-vektor und verfahren zur verwendung
|
|
KR100241300B1
(ko)
|
1993-11-16 |
2000-03-02 |
Sheldon A. Schaffer |
활성물질의 조절된 방출성을 갖는 소포
|
|
GB9326174D0
(en)
|
1993-12-22 |
1994-02-23 |
Biocine Sclavo |
Mucosal adjuvant
|
|
GB9326253D0
(en)
|
1993-12-23 |
1994-02-23 |
Smithkline Beecham Biolog |
Vaccines
|
|
AU2585395A
(en)
|
1994-05-09 |
1995-11-29 |
Chiron Corporation |
Retroviral vectors having a reduced recombination rate
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6429199B1
(en)
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
|
AUPM873294A0
(en)
|
1994-10-12 |
1994-11-03 |
Csl Limited |
Saponin preparations and use thereof in iscoms
|
|
WO1996017072A2
(en)
|
1994-11-30 |
1996-06-06 |
Chiron Viagene, Inc. |
Recombinant alphavirus vectors
|
|
US5482936A
(en)
|
1995-01-12 |
1996-01-09 |
Minnesota Mining And Manufacturing Company |
Imidazo[4,5-C]quinoline amines
|
|
UA56132C2
(uk)
|
1995-04-25 |
2003-05-15 |
Смітклайн Бічем Байолоджікалс С.А. |
Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
|
|
GB9513261D0
(en)
|
1995-06-29 |
1995-09-06 |
Smithkline Beecham Biolog |
Vaccines
|
|
AU6489996A
(en)
|
1995-07-14 |
1997-02-18 |
Somatogen, Inc. |
Methods for increasing protein expression
|
|
US5707829A
(en)
|
1995-08-11 |
1998-01-13 |
Genetics Institute, Inc. |
DNA sequences and secreted proteins encoded thereby
|
|
ATE424463T1
(de)
|
1996-05-06 |
2009-03-15 |
Oxford Biomedica Ltd |
Rekombinationsunfähige retrovirale vektoren
|
|
EP0942964A2
(en)
*
|
1996-11-22 |
1999-09-22 |
Human Genome Sciences, Inc. |
Thermostable polymerases having altered fidelity
|
|
WO1998040100A1
(en)
|
1997-03-10 |
1998-09-17 |
Ottawa Civic Loeb Research Institute |
USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE AS AN ADJUVANT
|
|
US6818222B1
(en)
|
1997-03-21 |
2004-11-16 |
Chiron Corporation |
Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
|
|
GB9712347D0
(en)
|
1997-06-14 |
1997-08-13 |
Smithkline Beecham Biolog |
Vaccine
|
|
GB9713156D0
(en)
|
1997-06-20 |
1997-08-27 |
Microbiological Res Authority |
Vaccines
|
|
DE69815692T2
(de)
|
1997-09-05 |
2004-04-29 |
Glaxosmithkline Biologicals S.A. |
Öl in wasser emulsionen mit saponinen
|
|
EP1900818A3
(en)
|
1997-11-06 |
2008-06-11 |
Novartis Vaccines and Diagnostics S.r.l. |
Neisserial antigens
|
|
DE69836977T2
(de)
|
1997-11-21 |
2007-10-18 |
Serono Genetics Institute S.A. |
Chlamydia pneumoniae genomische sequenzen und polypeptiden, fragmenten und anwendungen davon für nachweis, prevention und heilung
|
|
GB9725084D0
(en)
|
1997-11-28 |
1998-01-28 |
Medeva Europ Ltd |
Vaccine compositions
|
|
SG152917A1
(en)
|
1998-01-14 |
2009-06-29 |
Chiron Srl |
Neisseria meningitidis antigens
|
|
EP1053015A2
(en)
|
1998-02-12 |
2000-11-22 |
American Cyanamid Company |
Pneumococcal and meningococcal vaccines formulated with interleukin-12
|
|
US6303114B1
(en)
|
1998-03-05 |
2001-10-16 |
The Medical College Of Ohio |
IL-12 enhancement of immune responses to T-independent antigens
|
|
AU746163B2
(en)
|
1998-04-09 |
2002-04-18 |
Smithkline Beecham Biologicals (Sa) |
Adjuvant compositions
|
|
GB9808327D0
(en)
|
1998-04-20 |
1998-06-17 |
Chiron Spa |
Antidiotypic compounds
|
|
EP2261350A3
(en)
|
1998-05-01 |
2012-01-04 |
Novartis Vaccines and Diagnostics, Inc. |
Neisseria meningitidis antigens and compositions
|
|
US6562798B1
(en)
|
1998-06-05 |
2003-05-13 |
Dynavax Technologies Corp. |
Immunostimulatory oligonucleotides with modified bases and methods of use thereof
|
|
US6110929A
(en)
|
1998-07-28 |
2000-08-29 |
3M Innovative Properties Company |
Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
|
|
GB9817052D0
(en)
|
1998-08-05 |
1998-09-30 |
Smithkline Beecham Biolog |
Vaccine
|
|
WO2000009699A2
(en)
|
1998-08-14 |
2000-02-24 |
Chiron Corporation |
Method for producing yeast expressed hpv types 6 and 16 capsid proteins
|
|
CA2773698C
(en)
|
1998-10-16 |
2015-05-19 |
Glaxosmithkline Biologicals S.A. |
Adjuvant systems comprising an immunostimulant adsorbed to a metallic salt particle and vaccines thereof
|
|
JP2002529069A
(ja)
|
1998-11-12 |
2002-09-10 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
クラミジア・ニューモニエのゲノム配列
|
|
GB9828000D0
(en)
|
1998-12-18 |
1999-02-10 |
Chiron Spa |
Antigens
|
|
US20030130212A1
(en)
|
1999-01-14 |
2003-07-10 |
Rossignol Daniel P. |
Administration of an anti-endotoxin drug by intravenous infusion
|
|
US6551600B2
(en)
|
1999-02-01 |
2003-04-22 |
Eisai Co., Ltd. |
Immunological adjuvant compounds compositions and methods of use thereof
|
|
MY125202A
(en)
|
1999-03-19 |
2006-07-31 |
Smithkline Beecham Biologicals S A |
Vaccine
|
|
DE60039198D1
(de)
|
1999-03-26 |
2008-07-24 |
Vical Inc |
Adjuvanszusammensetzungen zur Erhöhung der Immunantwort bezüglich Polynukleotid-basierenden Impfstoffen
|
|
WO2000061761A2
(en)
|
1999-04-09 |
2000-10-19 |
Techlab, Inc. |
Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
|
|
EP1185691B1
(en)
|
1999-04-30 |
2009-04-29 |
Novartis Vaccines and Diagnostics, Inc. |
Neisseria genomic sequences and methods of their use
|
|
AU5561599A
(en)
|
1999-05-05 |
2000-11-21 |
Sterrenbeld Biotechnologie North America, Inc. |
Dna promoter sequence for gene expression
|
|
US6331539B1
(en)
|
1999-06-10 |
2001-12-18 |
3M Innovative Properties Company |
Sulfonamide and sulfamide substituted imidazoquinolines
|
|
GB9918319D0
(en)
|
1999-08-03 |
1999-10-06 |
Smithkline Beecham Biolog |
Vaccine composition
|
|
IL148672A0
(en)
|
1999-09-24 |
2002-09-12 |
Smithkline Beecham Biolog |
Use of combination of polyxyethylene sorbitan ester and octoxynol as adjuvant and its use in vaccines
|
|
HK1046861A1
(zh)
|
1999-09-24 |
2003-01-30 |
Smithkline Beecham Biologicals S.A. |
包括聚氧乙烯烷基酯或者醚以及至少一種非離子表面活性劑的佐劑
|
|
AU3108001A
(en)
|
2000-01-20 |
2001-12-24 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory nucleic acids for inducing a th2 immune response
|
|
PT1790660E
(pt)
|
2000-02-28 |
2012-09-17 |
Novartis Vaccines & Diagnostic |
Expressão heteróloga de proteínas de neisseria
|
|
EP1328641A2
(en)
|
2000-03-10 |
2003-07-23 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof
|
|
GB0007432D0
(en)
|
2000-03-27 |
2000-05-17 |
Microbiological Res Authority |
Proteins for use as carriers in conjugate vaccines
|
|
EP1297005B1
(en)
|
2000-07-03 |
2009-08-26 |
Novartis Vaccines and Diagnostics S.r.l. |
Immunisation against chlamydia pneumoniae
|
|
ES2334641T3
(es)
|
2000-09-01 |
2010-03-15 |
Novartis Vaccines And Diagnostics, Inc. |
Derivados aza heterociclicos y su uso terapeutico.
|
|
NZ524717A
(en)
|
2000-09-11 |
2004-09-24 |
Chiron Corp |
Quinolinone derivatives
|
|
JP2004509970A
(ja)
|
2000-09-26 |
2004-04-02 |
ハイブリドン・インコーポレイテッド |
位置的化学変化による免疫刺激オリゴヌクレオチドアナログの免疫刺激活性の調節
|
|
AU2002246592A1
(en)
*
|
2000-10-19 |
2002-08-06 |
Wisconsin Alumni Research Foundation |
Dna sequences of escherichia coli cft073
|
|
ES2330083T3
(es)
|
2000-10-27 |
2009-12-04 |
Novartis Vaccines And Diagnostics S.R.L. |
Acidos nucleicos y proteinas de estreptococos de los grupos a y b.
|
|
US6660735B2
(en)
|
2000-12-08 |
2003-12-09 |
3M Innovative Properties Company |
Urea substituted imidazoquinoline ethers
|
|
US6667312B2
(en)
|
2000-12-08 |
2003-12-23 |
3M Innovative Properties Company |
Thioether substituted imidazoquinolines
|
|
US6664264B2
(en)
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Thioether substituted imidazoquinolines
|
|
UA75622C2
(en)
|
2000-12-08 |
2006-05-15 |
3M Innovative Properties Co |
Aryl ether substituted imidazoquinolines, pharmaceutical composition based thereon
|
|
US6677347B2
(en)
|
2000-12-08 |
2004-01-13 |
3M Innovative Properties Company |
Sulfonamido ether substituted imidazoquinolines
|
|
US6660747B2
(en)
|
2000-12-08 |
2003-12-09 |
3M Innovative Properties Company |
Amido ether substituted imidazoquinolines
|
|
US6677348B2
(en)
|
2000-12-08 |
2004-01-13 |
3M Innovative Properties Company |
Aryl ether substituted imidazoquinolines
|
|
US6664260B2
(en)
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Heterocyclic ether substituted imidazoquinolines
|
|
US6664265B2
(en)
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Amido ether substituted imidazoquinolines
|
|
GB0103424D0
(en)
|
2001-02-12 |
2001-03-28 |
Chiron Spa |
Gonococcus proteins
|
|
US7524509B2
(en)
|
2001-03-09 |
2009-04-28 |
Id Biomedical Corporation Of Quebec |
Proteosome-liposaccharide vaccine adjuvant
|
|
WO2002091998A2
(en)
|
2001-05-11 |
2002-11-21 |
Aventis Pasteur, Inc. |
Novel meningitis conjugate vaccine
|
|
GB0115176D0
(en)
|
2001-06-20 |
2001-08-15 |
Chiron Spa |
Capular polysaccharide solubilisation and combination vaccines
|
|
EP1409013B1
(en)
|
2001-07-26 |
2009-11-18 |
Novartis Vaccines and Diagnostics S.r.l. |
Vaccines comprising aluminium adjuvants and histidine
|
|
GB0121591D0
(en)
|
2001-09-06 |
2001-10-24 |
Chiron Spa |
Hybrid and tandem expression of neisserial proteins
|
|
CN1599623B
(zh)
|
2001-09-14 |
2011-05-11 |
赛托斯生物技术公司 |
免疫刺激物向病毒样颗粒内的包装:制备方法与用途
|
|
WO2003024480A2
(en)
|
2001-09-14 |
2003-03-27 |
Cytos Biotechnology Ag |
In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
|
|
WO2003035836A2
(en)
|
2001-10-24 |
2003-05-01 |
Hybridon Inc. |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
|
|
GEP20074099B
(en)
|
2001-11-27 |
2007-05-10 |
Anadys Pharmaceuticals Inc |
3-β-D-RIBOFURANO-SYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
|
|
US7321033B2
(en)
|
2001-11-27 |
2008-01-22 |
Anadys Pharmaceuticals, Inc. |
3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof
|
|
GB0130123D0
(en)
*
|
2001-12-17 |
2002-02-06 |
Microbiological Res Agency |
Outer membrane vesicle vaccine and its preparation
|
|
US6677349B1
(en)
|
2001-12-21 |
2004-01-13 |
3M Innovative Properties Company |
Sulfonamide and sulfamide substituted imidazoquinolines
|
|
US20030165870A1
(en)
*
|
2002-03-01 |
2003-09-04 |
Blattner Frederick R. |
Novel sequences of E. coli CFT073
|
|
EP1342784A1
(en)
*
|
2002-03-06 |
2003-09-10 |
Mutabilis S.A. |
ExPEC-specific proteins, genes encoding them and uses thereof
|
|
EA007987B1
(ru)
|
2002-03-29 |
2007-02-27 |
Чирон Корпорейшн |
Замещённые бензазолы и их применение в качестве ингибиторов киназы raf
|
|
WO2003101949A2
(en)
|
2002-05-29 |
2003-12-11 |
3M Innovative Properties Company |
Process for imidazo[4,5-c]pyridin-4-amines
|
|
US6909196B2
(en)
|
2002-06-21 |
2005-06-21 |
Micron Technology, Inc. |
Method and structures for reduced parasitic capacitance in integrated circuit metallizations
|
|
FR2842210B1
(fr)
|
2002-07-09 |
2012-12-14 |
Mutabilis |
Determinants de pathogenicite utilisables comme cibles pour l'elaboration de moyens de prevention et de controle d'infections bacteriennes et/ou de la dissemination systemique
|
|
US7250443B2
(en)
|
2002-08-23 |
2007-07-31 |
Chiron Corporation |
Pyrrole based inhibitors of glycogen synthase kinase 3
|
|
GB0220194D0
(en)
*
|
2002-08-30 |
2002-10-09 |
Chiron Spa |
Improved vesicles
|
|
PT1551357E
(pt)
|
2002-09-13 |
2014-10-10 |
Novartis Vaccines & Diagnostic |
Vacina contra os estreptococos do grupo b
|
|
HUE031886T2
(en)
|
2002-10-11 |
2017-08-28 |
Glaxosmithkline Biologicals Sa |
Polypeptide vaccines for extensive protection against hypervirulent meningococcal lines
|
|
GB0227346D0
(en)
|
2002-11-22 |
2002-12-31 |
Chiron Spa |
741
|
|
US20040209370A1
(en)
|
2002-12-19 |
2004-10-21 |
Wonchul Suh |
Method for chromosomal engineering
|
|
US7521062B2
(en)
|
2002-12-27 |
2009-04-21 |
Novartis Vaccines & Diagnostics, Inc. |
Thiosemicarbazones as anti-virals and immunopotentiators
|
|
ES2391770T3
(es)
|
2003-01-21 |
2012-11-29 |
Novartis Vaccines And Diagnostics, Inc. |
Uso de compuestos de triptantrina para la potenciación inmune
|
|
GB0301554D0
(en)
|
2003-01-23 |
2003-02-26 |
Molecularnature Ltd |
Immunostimulatory compositions
|
|
EP1441036A1
(en)
|
2003-01-27 |
2004-07-28 |
Université de Nantes |
Method for the identification and isolation of strong bacterial promoters
|
|
US7893096B2
(en)
|
2003-03-28 |
2011-02-22 |
Novartis Vaccines And Diagnostics, Inc. |
Use of small molecule compounds for immunopotentiation
|
|
JP4896715B2
(ja)
|
2003-06-26 |
2012-03-14 |
ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド |
Ｃｈｌａｍｙｄｉａｔｒａｃｈｏｍａｔｉｓに対する免疫原性組成物
|
|
JP4049045B2
(ja)
|
2003-07-28 |
2008-02-20 |
トヨタ自動車株式会社 |
蓄熱装置付きエンジンシステム
|
|
CA2537742C
(en)
|
2003-09-15 |
2014-07-22 |
Chiron Corporation |
Immunogenic compositions for streptococcus agalactiae
|
|
RU2006134631A
(ru)
|
2004-03-02 |
2008-04-10 |
Чирон Корпорейшн (Us) |
Иммуногенные композиции против chlamidia pneumoniae
|
|
GB0424092D0
(en)
|
2004-10-29 |
2004-12-01 |
Chiron Srl |
Immunogenic bacterial vesicles with outer membrane proteins
|
|
JP2008530245A
(ja)
|
2005-02-18 |
2008-08-07 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド |
尿路病原性菌株由来の抗原
|